MED15 and cancer: MED15 is overexpressed in a wide range of human cancers: castration-resistant prostate cancer, head, and neck squamous cell carcinoma, hepatocellular carcinoma, breast cancer, renal cell carcinoma, and testicular germ cell tumors18–25.